CABG versus PCI in the Treatment of Unprotected Left Main Disease in Diabetics: A Literature Review.
CABG
PCI
acute coronary syndrome
cardiac
coronary intervention
left main coronary artery disease
stent
Journal
The International journal of angiology : official publication of the International College of Angiology, Inc
ISSN: 1061-1711
Titre abrégé: Int J Angiol
Pays: United States
ID NLM: 9504821
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
16
11
2021
Statut:
epublish
Résumé
The approach to left main coronary artery disease (CAD) in diabetic patients has been extensively debated. Diabetic patients have an elevated risk of left main disease in addition to multivessel disease. Previous trials have shown increased revascularization rates in percutaneous coronary intervention compared with coronary artery bypass grafting (CABG) but overall comparable outcomes, although many of these studies were not using the latest stent technology or CABG with arterial revascularization. Our aim is to review the most recent trials that have recently published long-term follow-up, as well as other literature pertaining to left main disease in diabetic patients. Furthermore, we will be discussing some future treatment strategies that could likely create a paradigm shift in how left main CAD is managed.
Identifiants
pubmed: 34776818
doi: 10.1055/s-0041-1735517
pii: 210066
pmc: PMC8580609
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
187-193Informations de copyright
International College of Angiology. This article is published by Thieme.
Déclaration de conflit d'intérêts
Conflict of Interest None declared.
Références
Hellenic J Cardiol. 2017 May - Jun;58(3):178-189
pubmed: 28212871
Heart. 2020 Sep;106(18):1380-1386
pubmed: 32522821
J Am Coll Cardiol. 2010 Feb 2;55(5):432-40
pubmed: 20117456
Expert Rev Cardiovasc Ther. 2017 Mar;15(3):157-163
pubmed: 28256180
Ann Cardiothorac Surg. 2018 Sep;7(5):621-627
pubmed: 30505746
Circulation. 2020 May 5;141(18):1437-1446
pubmed: 32223567
J Am Heart Assoc. 2019 Jul 2;8(13):e013032
pubmed: 31242821
Ann Med. 2020 Aug;52(5):225-232
pubmed: 32429711
N Engl J Med. 2016 Dec 8;375(23):2223-2235
pubmed: 27797291
Lancet Diabetes Endocrinol. 2013 Dec;1(4):317-28
pubmed: 24622417
Diabetes Ther. 2018 Oct;9(5):2163-2171
pubmed: 30220039
Cardiovasc Diabetol. 2017 Feb 10;16(1):23
pubmed: 28183306
Diabetol Metab Syndr. 2019 Dec 19;11:110
pubmed: 31890044
N Engl J Med. 2012 Dec 20;367(25):2375-84
pubmed: 23121323
JAMA. 2005 Mar 23;293(12):1501-8
pubmed: 15784875
Exp Clin Cardiol. 2011 Spring;16(1):16-22
pubmed: 21523202
Eur Heart J. 2012 May;33(10):1214-22
pubmed: 22447805
Sci Rep. 2019 May 13;9(1):7268
pubmed: 31086198
Ann Thorac Surg. 2011 Dec;92(6):2140-6
pubmed: 21967819
Cardiovasc Surg. 2003 Dec;11(6):497-505
pubmed: 14627973
Ann Thorac Surg. 2016 Sep;102(3):1012-1022
pubmed: 27217297
J Am Coll Cardiol. 2013 Feb 26;61(8):808-16
pubmed: 23428214
JACC Cardiovasc Interv. 2014 May;7(5):497-506
pubmed: 24746647
Ann Cardiothorac Surg. 2018 Jul;7(4):506-515
pubmed: 30094215
Angiology. 2019 Sep;70(8):765-773
pubmed: 30995117